Indaptus Therapeutics, Inc. Shares Issued, Price Per Share
Indaptus Therapeutics, Inc. (INDP) had Shares Issued, Price Per Share of $1.18 per share as of 2024-11-22, per its 10-K filed 2025-03-13.
Financial Statements › Notes
us-gaap:SharesIssuedPricePerShare · last filed 2025-03-13
- 2024-11-22: Shares Issued, Price Per Share $1.18.
- 2024-08-08: Shares Issued, Price Per Share $1.82.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2024-11-22 | $1.18 10-K · filed 2025-03-13 |
| 2024-08-08 | $1.82 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |